These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31665215)

  • 1. Fluoroquinolone Use and Seasonal Patterns of Ciprofloxacin Resistance in Community-Acquired Urinary Escherichia coli Infection in a Large Urban Center.
    Soucy JR; Schmidt AM; Quach C; Buckeridge DL
    Am J Epidemiol; 2020 Mar; 189(3):215-223. PubMed ID: 31665215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
    Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
    Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
    Fasugba O; Mitchell BG; Mnatzaganian G; Das A; Collignon P; Gardner A
    PLoS One; 2016; 11(10):e0164306. PubMed ID: 27711250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
    Yeshitela B; Gebre-Selassie S; Feleke Y
    Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint Modeling of Resistance to Six Antimicrobials in Urinary Escherichia coli Isolates in Quebec, Canada.
    Soucy JR; Schmidt AM; Frenette C; Dolcé P; Boudreault AA; Buckeridge DL; Quach C
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.
    Ramsey EG; Royer J; Bookstaver PB; Justo JA; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2019 Jul; 54(1):1-7. PubMed ID: 30885805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    Mulder M; Kiefte-de Jong JC; Goessens WH; de Visser H; Hofman A; Stricker BH; Verbon A
    J Antimicrob Chemother; 2017 Jan; 72(1):281-289. PubMed ID: 27655855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
    Low M; Neuberger A; Hooton TM; Green MS; Raz R; Balicer RD; Almog R
    Lancet Infect Dis; 2019 Apr; 19(4):419-428. PubMed ID: 30846277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis.
    Bryce A; Hay AD; Lane IF; Thornton HV; Wootton M; Costelloe C
    BMJ; 2016 Mar; 352():i939. PubMed ID: 26980184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
    Killgore KM; March KL; Guglielmo BJ
    Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.
    Fasugba O; Gardner A; Mitchell BG; Mnatzaganian G
    BMC Infect Dis; 2015 Nov; 15():545. PubMed ID: 26607324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trend and seasonality of community-acquired Escherichia coli antimicrobial resistance and its dynamic relationship with antimicrobial use assessed by ARIMA models.
    Asencio Egea MÁ; Huertas Vaquero M; Carranza González R; Herráez Carrera Ó; Redondo González O; Arias Arias Á
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Oct; 36(8):502-506. PubMed ID: 29217096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review.
    Stapleton AE; Wagenlehner FME; Mulgirigama A; Twynholm M
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32747356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.